Clinical Trials Browser

Phase 3 × Extensive Small Cell Lung Cancer × anlotinib × Clear all

NCT04234607 2020-01-22

A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)

Phase 3 Unknown

Extensive Small Cell Lung Cancer